Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antithrombin III producing hepatocellular carcinoma

K Akiyama1, K Nakamura, I Makino

  • 1Department of Clinical Pharmacology (TUMURA), Asahikawa medical college, Japan.

Thrombosis Research
|November 1, 1993
PubMed
Summary

This study reports a rare case of hepatocellular carcinoma associated with elevated Antithrombin III (AT-III) levels. Tumor cells were identified as the source of the increased AT-III, offering insights into this unique cancer presentation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Von Willebrand Factor Deposition and ADAMTS-13 Consumption in Allograft Tissue of Thrombotic Microangiopathy-like Disorder After Living Donor Liver Transplantation: A Case Report.

Transplantation proceedings·2017
Same author

Ischemia reperfusion-facilitated sinusoidal endothelial cell injury in liver transplantation and the resulting impact of extravasated platelet aggregation.

European surgery : ACA : Acta chirurgica Austriaca·2016
Same author

Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2015
Same author

Severe veno-occlusive disease/sinusoidal obstruction syndrome after deceased-donor and living-donor liver transplantation.

Transplantation proceedings·2014
Same author

Nuclear factor-κB regulates RANTES chemokine expression in response to tumor necrosis factor-α in fibroblast-like synoviocytes.

Modern rheumatology·2014
Same author

Thoracoscopic esophagectomy with extended lymph node dissection in the left lateral position: technical feasibility and oncologic outcomes.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2013

Area of Science:

  • Hepatology
  • Oncology
  • Biochemistry

Background:

  • Primary hepatocellular carcinoma (HCC) is a significant global health concern.
  • Elevated levels of coagulation factors are occasionally observed in HCC patients.
  • Antithrombin III (AT-III) is a key regulator of coagulation, typically decreasing in active disease.

Observation:

  • A 53-year-old male presented with HCC, negative for viral markers (HBV, HCV).
  • Imaging revealed multiple nodules in the right hepatic lobe; PIVKA-II was elevated, AFP was normal.
  • Coagulation tests showed significantly increased antigenic quantity and activity of Antithrombin III (AT-III).

Findings:

  • Immunohistochemical analysis confirmed HCC (Edmondson I) with positive staining for AT-III.
  • The tumor cells themselves were identified as the source of the abnormally high AT-III levels.

Related Experiment Videos

  • This represents a unique case of HCC with exaggerated AT-III production.

    • Implications:

    • This finding suggests a novel mechanism in certain HCC cases where tumor cells aberrantly produce AT-III.
    • Understanding this phenomenon may lead to new diagnostic markers or therapeutic strategies for specific HCC subtypes.
    • Further research is warranted to explore the clinical significance and underlying molecular pathways of AT-III overproduction in HCC.